New research has highlighted links between amyotrophic lateral sclerosis and type 2 diabetes.
Patients with amyotrophic lateral sclerosis (ALS) often suffer from type 2 diabetes. This phenomenon has since long remained mechanistically enigmatic. Now, researchers at Karolinska Institutet in Sweden have identified a molecular mechanism linking ALS and type 2 diabetes.
The researchers found that immunoglobulin G (IgG) antibodies in the blood of ALS patients target the calcium channel in the cell membrane of the insulin-secreting beta cells in the pancreas.
Dr Yue Shi, first author of the study and Postdoctoral researcher at the Department of Molecular Medicine and Surgery, Karolinska Institutet, said: “This leads to an unphysiological calcium (Ca2+) influx and consequent beta cell death.”
The study is published in the scientific journal PNAS.
Altered humoral immunity, i.e. the presence of autoantibodies targeting the body’s own cells, is a known phenomenon in type 1 diabetes.
The new study highlights the presence of autoantibodies as a pathogenic mechanism in a subgroup of patients with type 2 diabetes.
Dr Shao-Nian Yang, Associate professor at the Department of Molecular Medicine and Surgery, Karolinska Institutet, and senior author of the study, said: “We now demonstrate that IgG from ALS patients with type 2 diabetes behave like cytotoxic autoantibodies, suggesting that altered humoral immunity can serve as a critical pathogenic mechanism in the development of diabetes.
“This may lay the foundation for a new immunotherapy strategy for patients suffering from both ALS and diabetes.”
The researchers believe that the presence of autoantibodies may be a generalised phenomenon for other neurodegenerative diseases as well.
Professor Per-Olof Berggren, Director of the Rolf Luft Research Center, Karolinska Institutet, and another senior author of the study, said: “Interestingly, pancreatic beta cells and neurons are equipped with similar types of calcium channels and share a series of physiological and pathological mechanisms for their function/dysfunction and survival/death, such as Ca2+-dependent exocytosis and Ca2+-triggered cell death.
“The extent to which the pathogenic mechanism that we discovered in patients with both ALS and type 2 diabetes may be generalised to other neurodegenerative diseases associated with diabetes will be the focus for future studies.”